1997 U.S. Code
Title 21 - FOOD AND DRUGS
CHAPTER 20 - NATIONAL DRUG CONTROL PROGRAM
SUBCHAPTER I - OFFICE OF NATIONAL DRUG CONTROL POLICY
Sec. 1501 - Establishment of Office of National Drug Control Policy

View Metadata

§1501. Establishment of Office of National Drug Control Policy (a) Establishment of Office

There is established in the Executive Office of the President the “Office of National Drug Control Policy”.

(b) Director and Deputy Directors

(1) There shall be at the head of the Office of National Drug Control Policy a Director of National Drug Control Policy.

(2) There shall be in the Office of National Drug Control Policy a Deputy Director for Demand Reduction and a Deputy Director for Supply Reduction.

(3) The Deputy Director for Demand Reduction and the Deputy Director for Supply Reduction shall assist the Director in carrying out the responsibilities of the Director under this Act.

(c) Bureau of State and Local Affairs

(1) There is established in the Office of National Drug Control Policy a Bureau of State and Local Affairs.

(2) There shall be at the head of such bureau an Associate Director for National Drug Control Policy.

(d) Access by Congress

The location of the Office of National Drug Control Policy in the Executive Office of the President shall not be construed as affecting access by the Congress or committees of either House to—

(1) information, documents, and studies in the possession of, or conducted by or at the direction of the Director; or

(2) personnel of the Office of National Drug Control Policy.

(Pub. L. 100–690, title I, §1002, Nov. 18, 1988, 102 Stat. 4181.)

Repeal of Section

For repeal of section on Sept. 30, 1997, see section 1506 of this title.

References in Text

This Act, referred to in subsec. (b)(3), is Pub. L. 100–690, Nov. 18, 1988, 102 Stat. 4181, known as the Anti-Drug Abuse Act of 1988. For complete classification of this Act to the Code, see Short Title note set out under this section and Tables.

Effective Date

Section 1012 of Pub. L. 100–690, as amended by Pub. L. 105–20, §2(b), June 27, 1997, 111 Stat. 234, provided that: “This chapter [chapter 1 (§§1002–1012) of subtitle A of title I of Pub. L. 100–690, enacting this subchapter, amending section 1115 of this title, sections 5312, 5314, and 5315 of Title 5, Government Organization and Employees, section 1105 of Title 31, Money and Finance, and section 402 of Title 50, War and National Defense, repealing sections 1103, 1111 to 1114, 1116, and 1201 to 1204 of this title, enacting provisions set out as notes under sections 1201 and 1501 of this title, and repealing provisions set out as notes under section 1201 of this title] shall be effective January 21, 1989.”

Short Title of 1997 Amendment

Pub. L. 105–20, §1, June 27, 1997, 111 Stat. 224, provided that: “This Act [enacting subchapter II of this chapter and amending sections 1504, 1506 to 1508 of this title, section 2291 of Title 22, Foreign Relations and Intercourse, and provisions set out as notes under this section] may be cited as the ‘Drug-Free Communities Act of 1997’.”

Short Title

Section 1 of Pub. L. 100–690 provided that: “This Act [see Tables for classification] may be cited as the ‘Anti-Drug Abuse Act of 1988’.”

Section 1001 of Pub. L. 100–690 provided that: “This subtitle [subtitle A (§§1001–1048) of title I of Pub. L. 100–690, enacting this chapter, amending section 1115 of this title, sections 5312, 5314, and 5315 of Title 5, Government Organization and Employees, section 1105 of Title 31, Money and Finance, and section 402 of Title 50, War and National Defense, repealing sections 1103, 1111 to 1114, 1116, and 1201 to 1204 of this title, enacting provisions set out as notes under sections 1201 and 1501 of this title, and repealing provisions set out as notes under section 1201 of this title] may be cited as the ‘National Narcotics Leadership Act of 1988’.”

References to Subtitle A of Pub. L. 100–690

Pub. L. 105–20, §2(b), June 27, 1997, 111 Stat. 234, provided that: “Each reference in Federal law to subtitle A of the Anti-Drug Abuse Act of 1988 [see section 1001 of Pub. L. 100–690, set out above], with the exception of section 1001 of such subtitle, in any provision of law that is in effect on the day before the date of enactment of this Act [June 27, 1997] shall be deemed to be a reference to chapter 1 of the National Narcotics Leadership Act of 1988 [chapter 1 of subtitle A of title I of Pub. L. 100–690, see Effective Date note above] (as so designated by this section).”

Termination of National Drug Enforcement Policy Board; Transfer of Records and Property

Section 1007(a)(1), (2) of Pub. L. 100–690, as amended by Pub. L. 105–20, §2(b), June 27, 1997, 111 Stat. 234, provided that:

“(1) The National Drug Enforcement Policy Board is terminated effective on the 30th day after the first Director is confirmed by the Senate. Upon such termination, all records and property of the National Drug Enforcement Policy Board shall be transferred to the Director. The Director of the Office of Management and Budget shall take such actions as are necessary to facilitate such transfer.

“(2) All strategies, implementation plans, memoranda of understanding, and directives that have been issued or made by the National Drug Policy Board before the effective date of this chapter [Jan. 21, 1989] shall continue in effect until modified, terminated, superseded, set aside, or revoked by the President or the Director.”

Expenditure of Funds for Activities of National Narcotics Border Interdiction System

Section 1007(b) of Pub. L. 100–690 provided that no funds could be expended after 30 days after date on which first Director was confirmed by Senate for any activities or operations of entity otherwise known as the National Narcotics Border Interdiction System.

Termination of White House Office of Drug Abuse Policy

Section 1007(c)(2) of Pub. L. 100–690 provided that the White House Office of Drug Abuse Policy was to terminate on the 30th day after date on which first Director was confirmed by the Senate.

Executive Order No. 12696

Ex. Ord. No. 12696, Nov. 13, 1989, 54 F.R. 47507, as amended by Ex. Ord. No. 12756, Mar. 18, 1991, 56 F.R. 11903, which established the President's Drug Advisory Council, was revoked by Ex. Ord. No. 12869, §4(d), Sept. 30, 1993, 58 F.R. 51751, formerly set out as a note under section 14 of the Federal Advisory Committee Act in the Appendix to Title 5, Government Organization and Employees.

Ex. Ord. No. 12911. Seal for Office of National Drug Control Policy

Ex. Ord. No. 12911, Apr. 25, 1994, 59 F.R. 21121 [22121], provided:

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered as follows:

Section 1. There is approved for the Office of National Drug Control Policy in the Executive Office of the President an official seal described as follows:

On a blue disc the Arms of the United States proper above a curved gold scroll inscribed “OFFICE OF NATIONAL DRUG CONTROL POLICY” in blue letters, all within a white border edged in gold and inscribed “EXECUTIVE OFFICE OF THE PRESIDENT OF THE UNITED STATES” in blue letters.

This design is appropriate for the Office of National Drug Control Policy. The dark blue in this seal is suggested by the Seal of the President and denotes the direct organizational link of the Office of National Drug Control Policy with the Presidential office. The Arms of the United States refer to the entire Nation and represent the involvement in drug control policies that are necessary to assist the President in his role as Chief Executive of the United States.

Sec. 2. The seal shall be of the design that is attached hereto and made a part of this order.

William J. Clinton.

Section Referred to in Other Sections

This section is referred to in title 42 section 285o–4.